Molecularly Matched Therapy in the Context of Sensitivity, Resistance, and Safety; Patient Outcomes in End-Stage Cancer – The MetAction Study
Acta Oncologica - United Kingdom
doi 10.1080/0284186x.2020.1742377
Full Text
Open PDFAbstract
Available in full text
Date
March 25, 2020
Authors
Publisher
Informa UK Limited